Cite
HARVARD Citation
Vasista, A. et al. (2020). Survival and cardiac toxicity in patients with HER2‐positive, metastatic breast cancer treated with trastuzumab in routine clinical practice. Asia-Pacific journal of clinical oncology. 16 (1), pp. 34-38. [Online].